# Sant P. Chawla, MD, Santa Monica, CA – FDA Inspections

Source: https://www.keypedia.com/companies/sant-p-chawla-md/12b13bee-4e0f-4d72-a3a7-217e48fb68ef

> Inspection records and compliance data for Sant P. Chawla, MD in Santa Monica, California. 7 FDA inspections on record (1 OAI), 1 Form 483, last inspected June 30, 2026.

---

## Details

- Name: Sant P. Chawla, MD
- FEI Number: 3003868371
- Address Line 1: Sarcoma Oncology Center, 2811 Wilshire Blvd Ste 414
- City: Santa Monica
- State: California
- Zip Code: 90403
- Country Name: United States
- Address: Sarcoma Oncology Center, 2811 Wilshire Blvd Ste 414, Santa Monica, California 90403, United States
- Country: United States

## Related Documents

- [483 - Sant P. Chawla, MD - 2026-06-30](https://www.keypedia.com/records/483/sant-p-chawla-md/1152fde2-17e7-4262-aaad-e80f433e6fcc) — source: FDA, date: June 30, 2026
- [FDA Inspection 1324454 - Sant P. Chawla, MD - 2026-06-30](https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/3c3a42fe-8e34-4a8b-8a5c-0b64111ab2b9) — source: FDA, date: June 30, 2026
- [483 - Sant P. Chawla, MD - 2022-04-15](https://www.keypedia.com/records/483/sant-p-chawla-md/0a32a8a1-6d5e-481b-917d-19be4066a625) — source: FDA, date: April 15, 2022
- [FDA Inspection 1167324 - Sant P. Chawla, MD - 2022-04-15](https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/fc9ea0cd-7118-4192-be16-3f8f20ae2c42) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2022
- FDA Inspection 945678 - Sant P. Chawla, MD - 2015-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2015
- FDA Inspection 757044 - Sant P. Chawla, MD - 2011-12-13 — classification: No Action Indicated (NAI), source: FDA, date: December 13, 2011
- FDA Inspection 757043 - Sant P. Chawla, MD - 2011-11-30 — classification: No Action Indicated (NAI), source: FDA, date: November 30, 2011
- FDA Inspection 722028 - Sant P. Chawla, MD - 2011-04-29 — classification: No Action Indicated (NAI), source: FDA, date: April 29, 2011
- [FDA Inspection 604145 - Sant P. Chawla, MD - 2009-08-27](https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/6e65d272-0251-4f01-8690-84c1abbbd856) — classification: Official Action Indicated (OAI), source: FDA, date: August 27, 2009

## Related Companies

- [Corcept Therapeutics Incorporated](https://www.keypedia.com/companies/corcept-therapeutics-incorporated/9f3284cd-b285-4408-818e-19b78043d2e3)
- [Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe](https://www.keypedia.com/companies/caribe-holdings-cayman-co-ltd-dba-puracap-caribe/e746116a-a57b-4872-a647-5ea6d497ff3e)
- [Teva Branded Pharmaceutical Products R&D](https://www.keypedia.com/companies/teva-branded-pharmaceutical-products-rd/7e833f16-5791-422a-944a-bf999e8b8885)
- [Sunandana Chandra, M.D.](https://www.keypedia.com/companies/sunandana-chandra-md/a091d168-e82f-4647-bf29-22c91ba6fc32)
- [Donald J Garcia, Jr. M.D.](https://www.keypedia.com/companies/donald-j-garcia-jr-md/a9185c7c-8af7-4f76-83f6-d313765a3dae)
- [Omega Tech Labs, LLC](https://www.keypedia.com/companies/omega-tech-labs-llc/85cf5888-6344-4179-9b59-4610833d6f11)
- [Takeda Pharmaceuticals USA, Inc.](https://www.keypedia.com/companies/takeda-pharmaceuticals-usa-inc/678d8802-0216-41d5-bdd6-38999c144876)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928)
- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/5198bc9c-156b-4adf-ab9d-7ca6271a62bb)
- [Syneos Health](https://www.keypedia.com/companies/syneos-health/a2842cea-ef97-4a3d-92be-6af32c00ccaf)

## Related Officers

- [investigator](https://www.keypedia.com/people/sherri-n-rohlf/41090ab1-83d1-4e95-92ea-0cfca5cecdb6)
- [Jose A. Leyva](https://www.keypedia.com/people/jose-a-leyva/0c0ffdd3-cd41-4e30-bf61-e96f62a58921)
- [Bruno Baltazar](https://www.keypedia.com/people/bruno-baltazar/95a94f09-6e24-4454-a18d-4cef89e721d9)
